Clinical guidelines ‘Hyperprolactinemia’ (draft)-Reference-Cited by-同舟云学术

Clinical guidelines ‘Hyperprolactinemia’ (draft)

Published:2023-07-26 Issue:2 Volume:20 Page:170-188
ISSN:2306-5524
Container-title:Obesity and metabolism
language:
Short-container-title:Obes. metabol.

Author:

Dedov I. I.¹^ORCID,Melnichenko G. A.¹^ORCID,Dzeranova L. K.¹^ORCID,Andreeva E. N.¹^ORCID,Grineva E. N.²^ORCID,Marova E. I.¹^ORCID,Mokrysheva N. G.¹^ORCID,Pigarova E. A.¹^ORCID,Vorotnikova S. Y.¹^ORCID,Fedorova N. S.¹^ORCID,Shutova A. S.¹^ORCID,Przhiyalkovskaya E. G.¹^ORCID,Ilovaуskaya I. A.³^ORCID,Romantsova T. I.⁴^ORCID,Dogadin S. A.⁵^ORCID,Suplotova L. A.⁶^ORCID

Affiliation:

1. Endocrinology Research Centre

2. Almazov National Medical Research Centre

3. Moscow Regional Research and Clinical Institute

4. I.M.Sechenov First Moscow State Medical University

5. Krasnoyarsk State Medical University; Regional Clinical Hospital

6. Tyumen State Medical University

Abstract

Hyperprolactinemia is a persistent excess of the blood serum prolactin. The syndrome contains various symptoms, the most characteristic is a violation of the reproductive system. There are multiple endogenous and exogenous causes of hyperprolactinemia. The main treatment method is dopamine agonist therapy, in case of prolactinoma existence, surgical and radiation methods can be applied. About 15% of patients are resistant to dopamine agonist therapy, which determines creation of individual management tactics. The article presents a draft of clinical guidelines for the diagnosis and treatment of hyperprolactinemia, which provides a modern examination algorithm, discusses the basic principles of diagnostics and treatment approaches.

Publisher

Endocrinology Research Centre

Subject

Public Health, Environmental and Occupational Health,Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference117 articles.

1. Wang AT, Mullan RJ, Lane MA, et al. Treatment of hyperprolactinemia: A systematic review and meta-analysis. Syst Rev. 2006;1(1):1-12. doi: https://doi.org/10.1186/2046-4053-1-33

2. Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273-288. doi: https://doi.org/10.1210/jc.2010-1692

3. Donadio F, Barbieri A, Angioni R, et al. Patients with macroprolactinaemia: Clinical and radiological features. Eur J Clin Invest. 2007;37(7):552-557. doi: https://doi.org/10.1111/j.1365-2362.2007.01823.x

4. Joseph McKenna T. Should macroprolactin be measured in all hyperprolactinaemic sera? Clin Endocrinol (Oxf ). 2009;71(4):466-469. doi: https://doi.org/10.1111/j.1365-2265.2009.03577.x

5. Schlechte J, Dolan K, Sherman B, et al. The natural history of untreated hyperprolactinemia: A prospective analysis. Obstet Gynecol Surv. 1989;44(9):684-685. doi: https://doi.org/10.1097/00006254-198909000-00016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical aspects of the plurihormonal pituitary adenoma formation;South Russian Journal of Therapeutic Practice;2024-06-25

2. Mild hyperprolactinemia in clinical practice: the diagnostic “traps” and treatment strategy;Almanac of Clinical Medicine;2024-04-22

3. Cannulated prolactin test in the diagnosis of the hyperprolactinemia syndrome;Proceedings of the National Academy of Sciences of Belarus, Medical series;2024-03-04

4. Resistance to dopamine agonists in the treatment of prolactinomas: diagnostic criteria, mechanisms and ways to overcome it;Almanac of Clinical Medicine;2024-01-18